Rocchetti Talita T, Silbert Suzane, Gostnell Alicia, Kubasek Carly, Jerris Robert, Vong Jennifer, Widen Raymond
Esoteric Testing Laboratory, Pathology Department, Tampa General Hospital, Tampa, FL, USA.
Laboratório Especial de Microbiologia Clínica (LEMC), Federal University of São Paulo/UNIFESP, São Paulo, SP, Brazil.
Pract Lab Med. 2018 May 24;12:e00102. doi: 10.1016/j.plabm.2018.e00102. eCollection 2018 Nov.
The aim of this study was to develop a multiplex PCR test to detect (AX), (BC), (PSA) and (SM) directly from CF patient's respiratory samples using the open mode of the BD MAX™ System. A total of 402 CF respiratory samples were evaluated by culture and PCR. Specific sets of primers and probes for each target were designed in-house. Out of 402 samples tested, 196 were identified as negative and 206 as positive by culture for AX, PSA, BC and SM. Among culture positive samples, PCR detected 21/27 AX, 4/5 BC, 138/140 PSA and 29/34 SM. In addition, PCR assay identified 35 samples as positive that were initially negative by culture for those 4 targets. The CF BDM test proved to be an excellent tool to detect AX, BC, PSA and SM by real-time PCR on an automated platform.
本研究的目的是开发一种多重PCR检测方法,以使用BD MAX™系统的开放模式直接从囊性纤维化(CF)患者的呼吸道样本中检测(AX)、(BC)、(PSA)和(SM)。通过培养和PCR对总共402份CF呼吸道样本进行了评估。针对每个靶标自行设计了特定的引物和探针组。在检测的402份样本中,经培养鉴定,196份为AX、PSA、BC和SM阴性,206份为阳性。在培养阳性样本中,PCR检测到21/27的AX、4/5的BC、138/140的PSA和29/34的SM。此外,PCR检测还鉴定出35份样本为阳性,这些样本最初经培养对这4个靶标呈阴性。CF BDM检测被证明是一种通过自动平台上的实时PCR检测AX、BC、PSA和SM的优秀工具。